TWiki . Edumacation . StockPumpingTipRelease20020521 TWiki . { Main | Edumacation | TWiki | Test }
Edumacation . { Home | Users | Changes | Search | Go }
linked from Stock Pumping Tip Release web search for Stock Pumping Tip Release
Received: from kongmail.com ([63.87.252.37]) by hotmail.com with Microsoft SMTPSVC(5.0.2195.4905);
    Tue, 21 May 2002 07:35:43 -0700
Message-ID: 20020520.31.3054833044@kongmail.com
TO: mantel@hotmail.com
FROM: Super Savings Zone 
SUBJECT: HEALTHBRIDGE, INC. MARKETING INFECTIOUS WASTE STERILIZATION SYSTEMS
Content-type: text/html
Return-Path: dim@somehow.kongmail.com
X-OriginalArrivalTime: 21 May 2002 14:35:44.0540 (UTC) FILETIME=[CA3605C0:01C200D4]
Date: 21 May 2002 07:35:44 -0700

COMPANY PROFILE
If you do not wish to receive e-mail from Bargain Bazaar,
please click UNSUBSCRIBE


<IMG height=116 alt="" hspace=0 src="http://www.kongmail.com/email/images/html051602/tipmail_04.gif" width=139 border=0>
<IMG height=11 alt="" hspace=0 src="http://www.kongmail.com/email/images/html051602/email.gif" width=52 border=0>


<INPUT type=checkbox CHECKED value=1 name=OPTIN> I agree to the Tiprelease / theADmanager Contest Terms & Conditions Here
On January 23rd, 2002 Healthbridge Inc. <A rel="nofollow" href="http://www.kongmail.com/e/c.cgi?j=20020520_31&e=3054833044&r=u8268&d=6&p=2">(OTC-BB - HLBR) - (Berlin - HBZ) announced the acquisition of two advanced technologies from a private German company, B.I.M.E. GmbH. Healthbridge Inc. acquired both the Valides Modular Infectious Medical Waste Disposal System, and the Medides System, as well as all assets of the German company B.I.M.E. GmbH.
<FONT face=Arial color=#ffffff size=-1>Corporate Information
Exchange/Symbol OTCBB/HLBR
52 week range $0.09 - 0.55
Current Price $0.29XXXXX
Shares Outstanding 16.78 MM
Owned by Directors/Officers +- 6%
Public Float Est. 7 M shares
The Agreement requires the Company to pay the Sellers a total of $180,000 and 750,000 restricted shares in three installments. The company has paid the first two installments of cash, equaling approximately $100,064 and delivered the 750,000 restricted shares. The exact terms and conditions of the Agreement are described in a form 8-K filing made with the Securities and Exchange Commission ("Commission") on February 12, 2002. The Agreement was amended on March 28, 2002 to extend the payment date from March 31, 2002 to April 25, 2002 and on April 10, 2002 converting the final cash payment into a promissory note due in full on or before May 15, 2002. And on May 6, 2002 the final payment was negotiated into three instalment of E21,000 each due on May 15, June 15 and July 15, 2002.
INVESTMENT HIGHLIGHTS
B.I.M.E. GmbH developed two advanced technologies for the treatment of infectious medical wastes generated by hospitals, laboratories, dental offices, clinics, blood banks, and other facilities in the healthcare sector.
 
Healthcare facilities generate millions of tons of infectious waste every year. In Germany alone, hospitals dispose of more than 100,000 tons of infectious waste annually, with an even greater amount of infectious wastes being generated by blood banks, dialysis, medical research facilities, dental offices and veterinary clinics.
 
With the introduction of the "Clean Air Acts" many countries are enforcing environmental regulations that are resulting in the closure of hospital incinerators in many parts of North America, South America and Europe.
 
The cost of off-site disposal can be prohibitive, and the health and safety risks associated with transporting these hazardous wastes as well as the risk of liability in the event of accidents or contamination are encouraging hospitals and other medical and healthcare facilities to seek alternative means of managing infectious wastes.
 
With the healthcare sector seeking a cost effective and risk free solution for disinfecting medical wastes the on site solution is safer and far more ecologically responsible than transporting infectious wastes for processing and disposal off-site.
 
Healthbridge believes that the patented Valides and the Medides Systems can effectively quite environmental concerns and reduce the prohibitive expenses associated with the disposal of infectious waste. The reason why Valides and the Medides Systems can provide both cost and performance advantages over other infectious waste sterilization and disposal systems currently available, is due to the innovative technology adopted in designing the system. Unlike the large single chamber autoclaves now on the market, the Valides and Medides Systems are modular and can be scaled to customer's volume requirements. System modularity also enables competitive pricing for both large and small customers. The sterilization cycle is rapid, thereby facilitating high productivity, and the simple computerized operating system requires only one operator, even for larger hospitals. This system requires no chemicals, as wastes are disinfected by means of a pulsed vacuum and saturated steam, in accordance with the Federal Epidemic Act for medical waste class A, B and C, for the disposal of infectious waste.
 
Healthbridge, Inc. is developing worldwide markets for the patented Valides Modular Infectious Medical Waste Disposal System.
 
For more information on Healthbridge Inc. please contact Cary Martin at toll free 1-866-606-0000 or 1-604-602-1717. E-mail user ccmartain at domain radiant.net
 

<IMG height=120 alt=logo src="http://www.kongmail.com/email/images/html051602/mail.gif" width=60 align=left border=0> You originally joined tiprelease.com to win $5,000 and to receive other promotions or you signed up with a party that has contracted with tiprelease. Please <A rel="nofollow" href="http://tiprelease.com/unsubscribe.asp?em=&*TO;">CLICK HERE to <A rel="nofollow" href="http://tiprelease.com/unsubscribe.asp?em=&*TO;"><FONT face=arial size=1>Unsubscribe<FONT face=arial size=1>, replying to this email WILL NOT unsubscribe you, so please visit our web site. By unsubscribing today, you will no longer be eligible to win. tiprelease.com is simply an advertiser and any products/services advertised in this email are NOT offers from tiprelease.com. Any correspondence about the products/services should be directed to the company in the ad. tiprelease.com makes no warranties or representations, implied, expressed, or otherwise, of merchantability or fitness for any products/services advertised herein. Copyright 2001,2002 tiprelease.com, All Rights Reserved.
**IMPORTANT NOTICE AND DISCLAIMER FROM TIPRELEASE.COM **
The purpose of this advertisement, like any advertising, is to provide coverage and publicity for the advertising company, its products or services. The information provided in this advertisement is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject us to any registration requirement within such jurisdiction or country. Verify all claims and do your own due diligence. This advertisement is not a solicitation or recommendation to buy, sell or hold securities and does not provide an analysis of the financial position of the company. We recommend you use the information found in this advertisement as an initial starting point for conducting your own research on the advertised company in order to determine your own personal opinion of the company before investing. All information concerning the advertised company contained herein should be verified independently by an attorney, with such company and an independent licensed securities analyst. We are not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. Many states have established rules requiring the approval of a security by a state security administrator. Check with <A rel="nofollow" href="http://www.kongmail.com/e/c.cgi?j=20020520_31&e=3054833044&r=u5887&d=6&p=5">http://www.nasaa.org/ and call your state security administrator to determine whether a particular security is licensed for sale in your state. Many companies have information filed with state securities regulators and many will supply investors with additional information on request. All statements and opinions contained in this advertisement are the sole opinion of the authors and are subject to change without notice. We are not liable for any investment decisions by our readers. Readers should independently investigate and fully understand all risks before investing. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser or broker prior to completing any such purchase or sale decision. We are not registered investment advisers, or broker-dealers, or members of any financial regulatory bodies. The information contained in this advertisement is provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. We disclaim any and all liability as to the completeness or accuracy of the information and for any omissions of material facts. This advertisement may contain hyperlinks to web sites operated by third parties other than us. Such hyperlinks are provided for the reader's reference and convenience only. We are not responsible for the reliability of these external sites nor are we responsible for any of the contents, advertising, products, or other materials on such external sites. Our inclusion of hyperlinks to such web sites does not imply any endorsement of the material on such web sites or any association with their operators. Under no circumstances shall we be held responsible or liable, directly or indirectly, for any loss or damage caused or alleged to have been caused in connection with the use of or reliance on any content, goods, or services available on such external site. Any concerns regarding any external link should be directed to its respective site administrator or webmaster. We may refer to other sources of information, or other commentary. We intend to offer these items to readers as additional sources of information, but disclaim any implication that we endorse information contained in such outside sources. Any referral by us is no guarantee of the accuracy of any information provided by outside sources. As we disclaim any representation concerning source reliability, readers must contact information suppliers on their own and gauge to the reader's satisfaction the truthfulness of any source information. It should be understood that there is no guarantee past performance will be indicative of future results. Any reference to past performance(s) of companies previously advertised are specially selected to be referenced based on the favorable performance of these companies and the companies referenced may not be representative of all past advertised companies as not all past advertised companies may have performed as well. Readers are cautioned that small and micro-cap stocks are high-risk investments and that they may lose all or a portion of their investment if they make a purchase in our advertised stocks. In order to be in full compliance with the U.S. Securities Act of 1933, Section 17(b), we have received seven-thousand five hundred dollars ($7500.00 USD) and thirty-thousand (30,000) shares of free-trading common stock from a 3rd party for the distribution of this and other advertisements. Since we are receiving compensation in the advertised company there is an inherent conflict of interest in our statements and opinions and such statements and opinions cannot be considered independent. Furthermore, our associates and/or employees and/or principals may have stock positions in advertised companies purchased in the open market or in private transactions. These positions may be liquidated, without prior notification, even after we have made positive comments regarding the advertised company. The receipt of this information constitutes your acceptance of these terms and conditions. Reading this advertisement shall not create under any circumstances an offer to buy or sell stock in any company advertised. Nor shall it create any principal-agent relationship between the reader and us. The stocks of advertised companies may trade in fast moving, highly volatile markets, and any reader should observe the trading behavior of any advertised company prior to investing. Advertised stocks are often thinly traded and large sell orders will have a substantially negative impact on share price. Investors in advertised stocks may experience difficulty in selling shares without seeing a decline in market price and may have difficulty in finding ready buyers of their stock. Information within this advertisement contains "forward looking" statements within the meaning of Section 27(a) of the U.S. Securities Act of 1933 and Section 21(e) of the U.S. Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be forward looking statements. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could or might occur. We encourage our readers to invest carefully and read the investor information available at the web sites of the U.S. Securities and Exchange Commission (SEC) at http://www.sec.gov/ and the National Association of Securities Dealers (NASD) at http://www.nasd.com/. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm. The NASD has published information on how to invest carefully at its web site. Readers can review all public filings by companies at the SEC s EDGAR page. All information within this advertisement is qualified in its entirety by the detailed information and financial statements of the advertised company contained in its regulatory filings with the SEC.


Except at listed above, no contact information is available for the entity sending the abovementioned newsletter.

Topic StockPumpingTipRelease20020521 . { Edit | Ref-By | Attach | Diffs | r1.1 }
You must register before editing pages or using other extended features on this TWiki system.
Revision r1.1 - 21 May 2002 - 01:00 by EliMantel web search for EliMantel
Privacy Policy
Copyright © 2000-2005 by the contributing authors. All material on this collaboration tool is the property of the contributing authors. Collect email addresses here.
Ideas, requests, problems regarding TWiki? Send feedback.